Evidence of latent HPV infection in older Danish women with a previous history of cervical dysplasia.
Author
Hammer, AnneBlaakaer, Jan
de Koning, Maurits N C
Steiniche, Torben
Mejlgaard, Else
Svanholm, Hans
Roensbo, Mette T
Fuglsang, Katrine
Doorbar, John
Andersen, Rikke H
Quint, Wim G V
Gravitt, Patti E
Date
2022-04-28Journal
Acta obstetricia et Gynecologica ScandinavicaPublisher
Wiley-BlackwellType
Article
Metadata
Show full item recordAbstract
Introduction: Understanding whether human papillomavirus (HPV) may establish latency in the uterine cervix is important. A better understanding of HPV natural history is useful for clinical counseling of women attending screening and to accurately inform health prevention strategies such as screening and HPV vaccination. We evaluated the extent of latent HPV infections in older women with a history of abnormal cytology. Material and Methods: We conducted a cross-sectional study in Aarhus, Denmark, from March 2013 through April 2015. Women were enrolled if they underwent cervical amputation or total hysterectomy because of benign disease. Prior to surgery, women completed a questionnaire and a cervical smear was collected for HPV testing and morphological assessment. For evaluation of latency (i.e., no evidence of active HPV infection, but HPV detected in the tissue), we selected women with a history of abnormal cervical cytology or histology, as these women were considered at increased risk of harboring a latent infection. Cervical tissue underwent extensive HPV testing using the SPF10-DEIA-LipA25 assay. Results: Of 103 women enrolled, 26 were included in this analysis. Median age was 55 years (interquartile range [IQR] 52–65), and most women were postmenopausal and parous. The median number of sexual partners over the lifetime was six (IQR 3–10), and 85% reported no recent new sexual partner. Five women (19.2%) had evidence of active infection at the time of surgery, and 19 underwent latency evaluation. Of these, a latent infection was detected in 11 (57.9%), with HPV16 being the most prevalent type (50%). Nearly 80% (n = 14) of the 18 women with a history of previous low-grade or high-grade cytology with no treatment had an active or latent HPV infection, with latent infections predominating. HPV was detected in two of the six women with a history of high-grade cytology and subsequent excisional treatment, both as latent infections. Conclusions: HPV can be detected in cervical tissue specimens without any evidence of an active HPV infection, indicative of a latent, immunologically controlled infection. Modeling studies should consider including a latent state in their model when estimating the appropriate age to stop screening and when evaluating the impact of HPV vaccination. © 2022 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).Rights/Terms
© 2022 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).Identifier to cite or link to this item
http://hdl.handle.net/10713/18791ae974a485f413a2113503eed53cd6c53
10.1111/aogs.14362
Scopus Count
Collections
Related articles
- HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
- Authors: Gilham C, Sargent A, Kitchener HC, Peto J
- Issue date: 2019 Jun
- The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
- Authors: C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J
- Issue date: 2014 Apr
- Risk factors for cervical neoplasia in Denmark.
- Authors: Kjaer SK
- Issue date: 1998
- Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
- Authors: Castle PE, Stoler MH, Wright TC Jr, Sharma A, Wright TL, Behrens CM
- Issue date: 2011 Sep
- Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.
- Authors: Simms KT, Hall M, Smith MA, Lew JB, Hughes S, Yuill S, Hammond I, Saville M, Canfell K
- Issue date: 2017